Limitations of the Anti-idiotype Strategy for an HIV Vaccine

T–Cell Activation in Health and Disease ◽

10.1016/b978-0-12-252682-4.50029-9 ◽

1989 ◽

pp. 243-249

Author(s):

Peter C.L. Beverley ◽

Donald Healey ◽

K. Broadhurst ◽

Q.J. Sattentau

Keyword(s):

Download Full-text

Using Research and Expert Consultations to Develop Educational Materials for a National HIV Vaccine Research Initiative

PsycEXTRA Dataset ◽

10.1037/e521572014-145 ◽

2011 ◽

Author(s):

Bonny Bloodgood ◽

A. Cornelius Baker ◽

Elyse Levine ◽

Carol Schechter

Keyword(s):

Hiv Vaccine ◽

Vaccine Research ◽

Educational Materials ◽

Research Initiative

Download Full-text

Health Care Professionals: Answers about HIV Vaccine Research

PsycEXTRA Dataset ◽

10.1037/e536682012-001 ◽

2009 ◽

Keyword(s):

Health Care ◽

Health Care Professionals ◽

Hiv Vaccine ◽

Vaccine Research

Download Full-text

Men Who Have Sex with Men: Answers about HIV Vaccine Research

PsycEXTRA Dataset ◽

10.1037/e536662012-001 ◽

2009 ◽

Keyword(s):

Hiv Vaccine ◽

Vaccine Research ◽

Download Full-text

HIV vaccine suffers setback

Nature Reviews Drug Discovery ◽

10.1038/d41573-020-00026-y ◽

2020 ◽

Vol 19 (3) ◽

pp. 156-156

Author(s):

Asher Mullard

Keyword(s):

Download Full-text

Crowd-funded HIV vaccine project sparks debate

Nature ◽

10.1038/nature.2014.14675 ◽

2014 ◽

Author(s):

Erika Check Hayden

Keyword(s):

Download Full-text

Future of HIV vaccine unclear

Nature ◽

10.1038/news.2009.969 ◽

2009 ◽

Author(s):

Erika Check Hayden

Keyword(s):

Download Full-text

Clues emerge to explain first successful HIV vaccine trial

Nature ◽

10.1038/news.2011.541 ◽

2011 ◽

Author(s):

Ewen Callaway

Keyword(s):

Vaccine Trial ◽

Download Full-text

Faculty Opinions recommendation of Demographic and behavioral contextual risk groups among men who have sex with men participating in a phase 3 HIV vaccine efficacy trial: implications for HIV prevention and behavioral/biomedical intervention trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1061782.513708 ◽

2007 ◽

Author(s):

Susan Buchbinder

Keyword(s):

Hiv Prevention ◽

Risk Groups ◽

Hiv Vaccine ◽

Efficacy Trial ◽

Phase 3 ◽

Contextual Risk ◽

Biomedical Intervention ◽

Sex With Men ◽

Intervention Trials ◽

Hiv Vaccine Efficacy Trial

Download Full-text

Faculty Opinions recommendation of Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717497851.793456351 ◽

2012 ◽

Author(s):

Michael Keefer

Keyword(s):

Risk Behaviour ◽

Hiv Vaccine ◽

Efficacy Trial ◽

Phase 3 ◽

Vaccine Regimen ◽

Post Hoc Analysis ◽

Download Full-text

Faculty Opinions recommendation of New approaches to HIV vaccine development.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725546301.793518516 ◽

2016 ◽

Author(s):

Barry Rouse

Keyword(s):

Vaccine Development ◽

Hiv Vaccine ◽

Download Full-text